Clinicobiologic parameters influencing OS on univariate and multivariate analysis
Parameter . | HR . | OS, P . |
---|---|---|
Univariate analysis | ||
Age > 65 y | — | .000 |
Hb < 12 g/dL | — | .004 |
β2-Microglobulin level > 3 mg/L | — | .008 |
More than or equal to 2 cytogenetic alterations | — | .038 |
Alterations at 14q | — | .013 |
14q deletions | — | .007 |
TP53 deletion (FISH) | — | .035 |
Lymphocytes < 4 × 109/L | — | .027 |
Platelet count < 100 × 109 | — | .092 |
CD5 PB expression | — | .898 |
IGHV mutational status | — | .301 |
Karyotype, abnormal versus normal | — | .302 |
7q deletion | — | .494 |
+3/+3q | — | .379 |
6q deletion | — | .307 |
Multivariate analysis | ||
Age > 65 y | 3.102 | .000 |
Hb < 12 g/dL | 1.915 | .014 |
Parameter . | HR . | OS, P . |
---|---|---|
Univariate analysis | ||
Age > 65 y | — | .000 |
Hb < 12 g/dL | — | .004 |
β2-Microglobulin level > 3 mg/L | — | .008 |
More than or equal to 2 cytogenetic alterations | — | .038 |
Alterations at 14q | — | .013 |
14q deletions | — | .007 |
TP53 deletion (FISH) | — | .035 |
Lymphocytes < 4 × 109/L | — | .027 |
Platelet count < 100 × 109 | — | .092 |
CD5 PB expression | — | .898 |
IGHV mutational status | — | .301 |
Karyotype, abnormal versus normal | — | .302 |
7q deletion | — | .494 |
+3/+3q | — | .379 |
6q deletion | — | .307 |
Multivariate analysis | ||
Age > 65 y | 3.102 | .000 |
Hb < 12 g/dL | 1.915 | .014 |
HR indicates hazard risk; —, not applicable; and PB, peripheral blood.